J. C. Frölich

1.2k total citations
39 papers, 976 citations indexed

About

J. C. Frölich is a scholar working on Physiology, Pharmacology and Biochemistry. According to data from OpenAlex, J. C. Frölich has authored 39 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 11 papers in Pharmacology and 10 papers in Biochemistry. Recurrent topics in J. C. Frölich's work include Nitric Oxide and Endothelin Effects (9 papers), Inflammatory mediators and NSAID effects (8 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). J. C. Frölich is often cited by papers focused on Nitric Oxide and Endothelin Effects (9 papers), Inflammatory mediators and NSAID effects (8 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). J. C. Frölich collaborates with scholars based in Germany, South Africa and United Kingdom. J. C. Frölich's co-authors include Stefanie M. Bode‐Böger, Rainer H. Böger, Rainer Schmelzeisen, S. Schultze-Mosgau, Ulrich Förstermann, E. Schröder, U. Gerecke, Rudi Busse, Margarete Goppelt‐Strübe and Michael Löffler and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Annals of the Rheumatic Diseases and Cardiovascular Research.

In The Last Decade

J. C. Frölich

37 papers receiving 927 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. C. Frölich Germany 18 456 245 150 146 139 39 976
Miroslav Radenković Serbia 16 174 0.4× 139 0.6× 40 0.3× 160 1.1× 62 0.4× 52 795
Ju‐Tae Sohn South Korea 21 347 0.8× 249 1.0× 109 0.7× 268 1.8× 101 0.7× 121 1.3k
Sergio Castellani Italy 15 128 0.3× 287 1.2× 48 0.3× 108 0.7× 73 0.5× 56 898
Marie–Françoise Doursout United States 20 261 0.6× 355 1.4× 73 0.5× 274 1.9× 61 0.4× 74 1.6k
B. J. Gertz United States 21 276 0.6× 109 0.4× 82 0.5× 355 2.4× 213 1.5× 27 1.7k
Mustafa Arslan Türkiye 17 185 0.4× 127 0.5× 37 0.2× 116 0.8× 65 0.5× 161 1.2k
D. B. Frewin Australia 18 220 0.5× 281 1.1× 30 0.2× 142 1.0× 64 0.5× 91 1.2k
Seong‐Ho Ok South Korea 18 235 0.5× 148 0.6× 81 0.5× 180 1.2× 65 0.5× 77 861
Issam A. Mardini United States 11 250 0.5× 364 1.5× 394 2.6× 226 1.5× 1.0k 7.3× 16 1.6k
Hiroko Satoh Japan 17 155 0.3× 116 0.5× 73 0.5× 264 1.8× 81 0.6× 40 937

Countries citing papers authored by J. C. Frölich

Since Specialization
Citations

This map shows the geographic impact of J. C. Frölich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. C. Frölich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. C. Frölich more than expected).

Fields of papers citing papers by J. C. Frölich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. C. Frölich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. C. Frölich. The network helps show where J. C. Frölich may publish in the future.

Co-authorship network of co-authors of J. C. Frölich

This figure shows the co-authorship network connecting the top 25 collaborators of J. C. Frölich. A scholar is included among the top collaborators of J. C. Frölich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. C. Frölich. J. C. Frölich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frölich, J. C. & W. Kirch. (2003). Praktische Arzneitherapie.
2.
Folino-Gallo, Pietro, T Walley, J. C. Frölich, Alfonso Carvajal, & I. Ralph Edwards. (2001). Availability of medicines in the European Union: results from the EURO-Medicines project. European Journal of Clinical Pharmacology. 57(6-7). 441–446. 7 indexed citations
3.
Stichtenoth, Dirk O., et al.. (2001). Drug expenditure in hospitals: what do German ward physicians know?. British Journal of Clinical Pharmacology. 51(4). 342–344. 6 indexed citations
4.
Bode‐Böger, Stefanie M., et al.. (2000). Role of Endogenous Nitric Oxide in Circadian Blood Pressure Regulation in Healthy Humans and in Patients with Hypertension or Atherosclerosis. Journal of Investigative Medicine. 48(2). 126–132. 56 indexed citations
5.
Bode‐Böger, Stefanie M., et al.. (1999). L-arginine Stimulates NO-Dependent Vasodilation in Healthy Humans—Effect of Somatostatin Pretreatment. Journal of Investigative Medicine. 47(1). 43–50. 39 indexed citations
6.
Phivthong‐ngam, Laddawal, et al.. (1998). Effect of Lovastatin on Plaque Formation and Ldl Oxidation in Cholesterol-Fed Rabbits. 20(1). 11–22. 1 indexed citations
7.
Tsikas, Dimitrios, et al.. (1998). Measurement of nitrite and nitrate in plasma, serum and urine of humans by high-performance liquid chromatography, the Griess assay, chemiluminescence and gas chromatography-mass spectrometry: interferences by biogenic amines and N(G)-nitro-L-arginine analogs.. PubMed. 715(2). 441–4; discussion 445. 21 indexed citations
8.
Wagner, Brunhilde, et al.. (1998). Effect of Selective Inhibition of the Inducible Cyclooxygenase on Renin Release in Healthy Volunteers. Journal of Investigative Medicine. 46(6). 290–296. 30 indexed citations
9.
Böger, Rainer H., Stefanie M. Bode‐Böger, & J. C. Frölich. (1996). [Pathogenetic aspects of the L-arginine-NO metabolic pathway in arteriosclerosis and possible therapeutic aspects].. PubMed. 25(4). 305–16. 1 indexed citations
10.
Stichtenoth, Dirk O., J. Wollenhaupt, D. Andersone, H. Zeidler, & J. C. Frölich. (1995). ELEVATED SERUM NITRATE CONCENTRATIONS IN ACTIVE SPONDYLOARTHROPATHIES. Lara D. Veeken. 34(7). 616–619. 20 indexed citations
11.
Frölich, J. C.. (1995). Prostaglandin endoperoxide synthetase isoenzymes: the clinical relevance of selective inhibition.. Annals of the Rheumatic Diseases. 54(12). 942–943. 24 indexed citations
12.
Schultze-Mosgau, S., et al.. (1995). Use of ibuprofen and methylprednisolone for the prevention of pain and swelling after removal of impacted third molars. Journal of Oral and Maxillofacial Surgery. 53(1). 2–7. 153 indexed citations
13.
Bode‐Böger, Stefanie M., et al.. (1994). Long term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in rats. Cardiovascular Research. 28(4). 494–499. 73 indexed citations
14.
Schmelzeisen, Rainer, et al.. (1992). [Combined analgetic drug treatment with ibuprofen after 3rd molar osteotomy].. PubMed. 14(6). 442–6. 1 indexed citations
15.
Frölich, J. C.. (1990). Prostacyclin in hypertension.. PubMed. 8(4). S73–8. 21 indexed citations
16.
Schmelzeisen, Rainer, et al.. (1989). [Sonographic objectivation of cheek swelling following perioperative edema prevention using dexamethasone during third molar osteotomies].. PubMed. 12(3). 233–9. 1 indexed citations
17.
Frölich, J. C., et al.. (1986). The effects of metamizol on prostaglandin synthesis in man.. PubMed. 19. 155–66. 9 indexed citations
18.
Rosenkranz, Bernd & J. C. Frölich. (1985). Plasma concentrations and anti-platelet effects after low dose acetylsalicylic acid. Prostaglandins Leukotrienes and Medicine. 19(3). 289–300. 24 indexed citations
19.
Frölich, J. C.. (1978). Methods in prostaglandin research. Raven Press eBooks. 14 indexed citations
20.
Frölich, J. C., et al.. (1977). Disease of the liver associated with alpha1-antitrypsin deficiency.. PubMed. 117(3). 264–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miroslav Radenković Breakdown of academic impact, for papers by Ju‐Tae Sohn Breakdown of academic impact, for papers by Sergio Castellani Breakdown of academic impact, for papers by Marie–Françoise Doursout Breakdown of academic impact, for papers by B. J. Gertz Breakdown of academic impact, for papers by Mustafa Arslan Breakdown of academic impact, for papers by D. B. Frewin Breakdown of academic impact, for papers by Seong‐Ho Ok Breakdown of academic impact, for papers by Issam A. Mardini Breakdown of academic impact, for papers by Hiroko Satoh
Rankless by CCL
2026